Clincosm LogoSign in Get a demo

Liver Cancer

Showing 76 - 100 of 503
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Liver Cancer Trial in France (Yttrium-90 loaded SIR-Spheres microspheres, QLQ-C30 with HCC module)

Completed
  • Liver Cancer
  • Yttrium-90 loaded SIR-Spheres microspheres
  • QLQ-C30 with HCC module
  • Angers, France
  • +12 more
Aug 12, 2022

Hepatoblastoma, Hepatocellular Carcinoma (HCC), Liver Tumors Trial in Boston (ET140203 T Cells)

Recruiting
  • Hepatoblastoma
  • +5 more
  • ET140203 T Cells
  • Boston, Massachusetts
    Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Aug 12, 2022

Liver Cancer Trial in Durham (Quality of life questionnaires)

Recruiting
  • Liver Cancer
  • Quality of life questionnaires
  • Durham, North Carolina
  • +1 more
Aug 10, 2022

Hepatocellular Carcinoma, Solid Tumor, Hepatocellular Carcinoma Non-resectable Trial in San Antonio (OTX-2002, Tyrosine kinase

Not yet recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • San Antonio, Texas
    Next Oncology
Aug 9, 2022

Intestinal Microbiome, Oral Microbiome, and Whole Blood

Recruiting
  • Gastrointestinal Cancer
  • +6 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Aug 5, 2022

    Liver Cancer, Cancer, Treatment-Related Trial (Additional margin coagulation)

    Not yet recruiting
    • Liver Cancer
    • Cancer, Treatment-Related
    • Additional margin coagulation
    • (no location specified)
    Aug 5, 2022

    Lung Cancer, Liver Cancer, Breast Cancer Trial in Halifax (CBCT Imaging)

    Not yet recruiting
    • Lung Cancer
    • +3 more
    • CBCT Imaging
    • Halifax, Nova Scotia, Canada
      Nova Scotia Health (QEII)
    Aug 3, 2022

    Minimally Invasive and Open Liver Surgery in Different

    Active, not recruiting
    • Liver Cancer
    • +2 more
    • Minimally invasive liver resection
    • Brescia, Italy
      Fondazione Poliambulanza Istituto Ospedaliero
    Jul 22, 2022

    Hepatocellular Carcinoma, HCC, Liver Cancer Trial in Hong Kong (Nivolumab, Hepatectomy)

    Completed
    • Hepatocellular Carcinoma
    • +2 more
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    Jul 20, 2022

    Breast Cancer, Liver Cancer, Prostate Cancer Trial in Bronx, New York (Clinical trial match-list, Match-list intervention)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • Clinical trial match-list
    • Match-list intervention
    • Bronx, New York
    • +2 more
    Jul 20, 2022

    Esophageal Cancer, Kidney Cancer, Larynx Cancer Trial in Saint Louis (Balloon-tipped catheter)

    Not yet recruiting
    • Esophageal Cancer
    • +12 more
    • Balloon-tipped catheter
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jul 19, 2022

    Hepatocellular Carcinoma, Microwave Ablation, Liver Cancer Trial in Changsha (Microwave ablation, Lenvatinib)

    Recruiting
    • Hepatocellular Carcinoma
    • +4 more
    • Changsha, Hunan, China
      Hunan Provincial People's Hospital
    Jul 8, 2022

    Hepatocellular Carcinoma(HCC) After Systemic Treatments

    Enrolling by invitation
    • Liver Cancer
    • +4 more
    • questionnaire survey
    • Wenzhou, Zhejiang, China
      Gang Chen
    Jul 1, 2022

    Hepatocellular Carcinoma, Liver Cancer, Liver Tumor Trial in United States (ET140203 autologous T cell product)

    Recruiting
    • Hepatocellular Carcinoma
    • +3 more
    • ET140203 autologous T cell product
    • Duarte, California
    • +3 more
    Jul 1, 2022

    Utilization of MAsS in Patients Undergoing LT for HCC

    Recruiting
    • NAFLD
    • +5 more
      • New York, New York
        Columbia University Irving Medical Center
      Jun 29, 2022

      Sarcopenia on HCC After Lenvatinib and Anti-PD-1 Treatment

      Enrolling by invitation
      • Liver Cancer
      • Sarcopenia
      • gait speed; ct scan; grip strength and chair stand test
      • Wenzhou, Zhejiang, China
        Gang Chen
      Jun 29, 2022

      Deep Learning Model for the Prediction of Post-LT HCC Recurrence

      Completed
      • Liver Transplant Disorder
      • +2 more
      • Liver transplantation
      • Rome, RM, Italy
        Quirino Lai
      Jun 27, 2022

      Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

      Active, not recruiting
      • Breast Cancer
      • +10 more
      • Los Angeles, California
      • +7 more
      Jun 21, 2022

      Gastric Cancer, Pancreatic Cancer, Liver Cancer Trial in Xiamen (18F-FDG, 18F-AlF-FAPI PET/CT)

      Recruiting
      • Gastric Cancer
      • +2 more
      • 18F-FDG, 18F-AlF-FAPI PET/CT
      • Xiamen, Fujian, China
        The First affiliated hospital of xiamen university
      Jun 20, 2022

      Liver Cancer, Sarcopenia Trial in Wenzhou (gait speed; ct scan;grip strength and chair stand test)

      Enrolling by invitation
      • Liver Cancer
      • Sarcopenia
      • gait speed; ct scan;grip strength and chair stand test
      • Wenzhou, Zhejiang, China
        Gang Chen
      Jun 14, 2022

      Hepatobiliary Tumors Tissue Samples Acquisition

      Recruiting
      • Hepatocellular Carcinoma
      • +7 more
      • Gene expression analysis
      • +10 more
      • Beijing, Beijing, China
        Chinese Academy of Medical Sciences & Peking Union Medical Colle
      Jun 8, 2022

      Multi- Target Hepatocellular Carcinoma Test in Increased Risk

      Recruiting
      • Hepatocellular Carcinoma
      • +4 more
      • Study CT/MRI Imaging
      • +2 more
      • Chandler, Arizona
      • +33 more
      May 27, 2022

      Liver Cancer Trial in Luzhou (FluoAB)

      Recruiting
      • Liver Cancer
      • Luzhou, Sichuan, China
        The Affiliated Hospital of Southwest Medical University
      May 26, 2022

      Liver Cancer, Hepatocellular Carcinoma, Metastatic Colorectal Cancer Trial in Boston (Standard microcatheter, PEDD device)

      Recruiting
      • Liver Cancer
      • +2 more
      • Standard microcatheter
      • PEDD device
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      May 17, 2022

      HCC, Liver Cancer Trial in Hong Kong (Prototype artificial intelligence algorithm, LI-RADS)

      Recruiting
      • HCC
      • Liver Cancer
      • Prototype artificial intelligence algorithm
      • LI-RADS
      • Hong Kong, Hong Kong
        Department of Medicine, The University of Hong Kong, Queen Mary
      May 17, 2022